These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3274828

  • 21. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival.
    Claesson K, Larsson P, Holmdahl R, Klareskog L, Forsum U, Tufveson G.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163
    [No Abstract] [Full Text] [Related]

  • 22. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H, Miyano T, Yamataka A, Yamataka T, Yagita H, Eto H, Ligo Y, Tansyo S, Kojima Y, Tamatani T.
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [Abstract] [Full Text] [Related]

  • 23. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
    Stepkowski SM, Tu Y, Condon TP, Bennett CF.
    Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
    [No Abstract] [Full Text] [Related]

  • 24. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH, Tanigawa M, Matsuzaki M, Onitsuka T, Shibata K, Koga Y, Suzuki H, Yamashita A, Miyamoto M, Li XK, Suzuki S, Amemiya H, Yokoi Y, Iwaya M, Yamaguchi A, Masaki Y, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract] [Full Text] [Related]

  • 25. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H, Seino K, Kano M, Sato K, Azuma M, Yagita H, Okumura K.
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract] [Full Text] [Related]

  • 26. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
    Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ.
    Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T, Knoop CJ, Hesse CJ, Vaessen LM, Balk AH, Yzermans JN, Weimar W.
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function?
    Tellides G, Dallman MJ, Morris PJ.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):997-8. PubMed ID: 2650306
    [No Abstract] [Full Text] [Related]

  • 32. Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
    Kupiec-Weglinski JW, van der Meide P, Stunkel KG, Tanaka K, Diamantstein T, Tilney NL.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):992-3. PubMed ID: 2495637
    [No Abstract] [Full Text] [Related]

  • 33. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T, Mulder AH, Balk AH, Mochtar B, Hesse CJ, Baan CC, Vaessen LM, Weimar W.
    J Heart Lung Transplant; 1995 Feb; 14(2):346-50. PubMed ID: 7779855
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]

  • 36. Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
    Tanaka K, Turka LA, Ueda H, Diamantstein T, Milford EL, Carpenter CB, Tilney NL, Kupiec-Weglinski JW.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):475-6. PubMed ID: 2523145
    [No Abstract] [Full Text] [Related]

  • 37. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T, Zietse R, Yzermans JN, Rischen-Vos J, Vaessen LM, Weimar W.
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract] [Full Text] [Related]

  • 38. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M.
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract] [Full Text] [Related]

  • 39. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
    Xia J, Jiang X, Huang Y, Zhang K, Xiao S, Yang C.
    Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
    [Abstract] [Full Text] [Related]

  • 40. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H, Hara MH, Miyahara T, Tanigawa M, Matsuzaki Y, Onitsuka T, Shibata K, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Iwaya M, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.